Abstract
Adenosine A2a receptor, a member of the G protein-coupled receptor superfamily, has been demonstrated to be an important pharmacological target. It couples to stimulatory G protein and activates adenylate cyclase upon agonist stimulation. Here we attempted to stably transfect Chinese hamster ovary (CHO-K1) cells, which lack any known subtypes of adenosine receptors, with recombinant human adenosine A2a receptors (hA2aR). Rapid down-regulation of hA2aR in a clonal cell line, CHOA2a-2, was observed over a short period of time in culture. This is consistent with other groups' findings of low expression and poor G protein coupling of this receptor in several cell systems. To facilitate pharmacological profiling for hA2aR ligand, we introduced a cyclic AMP response element (CRE)-linked β-galactosidase reporter gene into CHOA2a-2 cells to generate a stable cell line, CHOA2a-2CREβgal#26. Robust cyclic AMP signal amplification was obtained using a colorimetric assay measuring β-galactosidase activity. The EC50 of 5′-N-ethylcarboxamidoadenosine (NECA), a potent A2a agonist, for inducing β-galactosidase activity was 23.3 ± 3.5 nM, similar to 22.7 ± 3.9 nM, which was the NECA EC50 in the direct measurement of cyclic AMP of CHOA2a-2 cells in early culture. Subsequently we validated this assay for high throughput screening for hA2aR agonists. The Z′ factor for robotic assay performance was 0.79 ± 0.03, the ratio of signal/noise was 157 ± 36, and the ratio of signal/background was 10.6 ± 1.2, demonstrating that this assay is well suitable for quality high throughput screening. High throughput screening of Johnson & Johnson libraries uncovered a couple of distinct series of nonadenosine small molecules, in addition to adenosine analogues, as potential hA2aR agonists with EC50 values of 2–6 μM. Preliminary characterization of those compounds was presented.
Get full access to this article
View all access options for this article.